Search

ProQR's participation in the JMP Securities investor conference.

ProQR's participation in the Evercore ISI 4th Annual HealthCONx Conference.

ProQR's participation in the Chardan 5th Annual Genetic Medicines Conference.

ProQR's participation in the HC Wainwright 23rd Annual Global Investment Conference.

ProQR Expert Perspectives Series on Usher Syndrome and Retinitis Pigmentosa

ProQR will be at the TIDES USA meeting, May 7-10, 2023 in San Diego, CA, USA.

ProQR presentation and panel session at the Oligonucleotide and Precision Therapeutics (OPT) Congress

ProQR management will host an investor conference call and webcast to discuss the Company’s Axiomer RNA editing technology platform following the recently announced partnership with Lilly.